'Legacy will live on': Hundreds gather in Dubai to mourn renowned Indian doctor
Hundreds of people gathered at Al Quoz cemetery late on Sunday to bid farewell to Dr Nazar Moopan, a well-loved member of the medical community and nephew of Dr Azad Moopen, Founder Chairman of Aster DM Healthcare.
Well-wishers and friends flew in from India and other Gulf countries to pay their respects to the doctor who passed away peacefully in Dubai on Sunday, surrounded by his family.
'It is with deep sorrow and a profound sense of loss that we mourn the passing of Dr Nazar Moopan,' said Dr Azad Moopen. 'Dr Nazar was not only a pillar of our medical community but also a compassionate doctor, a committed leader, and a beloved colleague to many within the Aster family.
For over two decades, Dr Nazar has worked at Aster DM Healthcare and at the time of his death, he was the Medical Director and ENT Consultant at the group's facility in Qatar. He is survived by his wife Wahida and his children Neda, Nimmi and Zain.
According to Dr Azad, Dr Nazar 'dedicated his life to the service of others' for decades, exemplifying the values of integrity, excellence, and empathy. 'His contributions to healthcare in Qatar have left an indelible mark, and his legacy will live on through the countless lives he touched with his skill and kindness,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
3 hours ago
- Khaleej Times
'Legacy will live on': Hundreds gather in Dubai to mourn renowned Indian doctor
Hundreds of people gathered at Al Quoz cemetery late on Sunday to bid farewell to Dr Nazar Moopan, a well-loved member of the medical community and nephew of Dr Azad Moopen, Founder Chairman of Aster DM Healthcare. Well-wishers and friends flew in from India and other Gulf countries to pay their respects to the doctor who passed away peacefully in Dubai on Sunday, surrounded by his family. 'It is with deep sorrow and a profound sense of loss that we mourn the passing of Dr Nazar Moopan,' said Dr Azad Moopen. 'Dr Nazar was not only a pillar of our medical community but also a compassionate doctor, a committed leader, and a beloved colleague to many within the Aster family. For over two decades, Dr Nazar has worked at Aster DM Healthcare and at the time of his death, he was the Medical Director and ENT Consultant at the group's facility in Qatar. He is survived by his wife Wahida and his children Neda, Nimmi and Zain. According to Dr Azad, Dr Nazar 'dedicated his life to the service of others' for decades, exemplifying the values of integrity, excellence, and empathy. 'His contributions to healthcare in Qatar have left an indelible mark, and his legacy will live on through the countless lives he touched with his skill and kindness,' he said.
Khaleej Times
10 hours ago
- Khaleej Times
No more insulin injections for diabetes patients? UAE doctors explain cell-based treatment
Many diabetic patients abroad have said goodbye to insulin injections or now use them less frequently and in lower doses, according to doctors who noted patients recovered after undergoing a simple surgical procedure to transplant pancreatic cells. "50 per cent of patients with Type 1 diabetes — who typically rely on insulin injections — have been cured through 'islet cell transplantation'," Dr Tahra Abdalla Al Ali, a pediatrician based in the UAE, told Khaleej Times. "This has cured people of their pancreas's inability to produce insulin. Patients will no longer depend on insulin as they look forward to a future without constant insulin management.' Dr Al Ali noted, 'In 25 cases, pancreatic cells were transplanted; and the success rate for this group was 85 per cent. Of the patients, 50 per cent completely stopped using medication. The remaining group members use injections at lower doses and less frequently.' Stay up to date with the latest news. Follow KT on WhatsApp Channels. This treatment, which aims to benefit all patient groups, initially targeted individuals over the age of 20 who suffered from complications of diabetes and had difficulty maintaining healthy levels for an extended period. Procedure explained Dr Al Ali said islet cell transplantation involves transplanting pancreatic cells extracted from donors and studying them in specialised laboratories. Once the safety of these samples is confirmed, they are injected into the patient using a catheter-like method through the skin into a vein and then transplanted onto the liver. 'The transplanted cells help restore and regulate blood sugar levels in patients with type 1 diabetes, preventing severe, life-threatening hypoglycemia episodes and allowing patients to eliminate their daily insulin injections,' she added. Simple and safe The procedure is considered an alternative to the complete pancreas transplant to avoid surgical complications, including organ rejection and bleeding. It is regarded as a safe and simple treatment method. The Emirates Health Services (EHS), in collaboration with the University of Chicago, is working to treat patients from the UAE either abroad or by bringing experts to the country to provide care. Only for Type 1 diabetes The procedure is used exclusively for patients with Type 1 diabetes, where the main issue is the destruction of insulin-producing beta cells, Dr Patanjali Panduranga, endocrinologist at Aster Hospital, explained. It is not considered a treatment for Type 2 diabetes, where insulin resistance is the primary problem. However, some early studies are exploring its use in selected cases of insulin-dependent type 2 diabetes, although this remains under investigation. He noted the US Food and Drug Administration (FDA) approved islet cell transplantation in 2023 for adults with Type 1 diabetes who experienced severe hypoglycemia or poor glucose control despite intensive insulin therapy. Limitations remain 'Although the procedure has shown promising results, including insulin independence in up to 50 per cent of recipients, its broader clinical use remains limited due to the need for lifelong immunosuppression and the scarcity of suitable donor cells,' said Dr Panduranga. Dr Arvind Gaddameedi, another endocrinologist at Aster Clinic, explained that the success of islet cell transplantation depends on two key factors, safety and sustainability. Unlike full organ transplants, this procedure involves a 30-minute infusion under local anesthesia, making it accessible even to high-risk patients. However, challenges remain. One of the challenges is the availability of donor cells. While organ donation rates vary globally, innovations in islet cell processing, cryopreservation, and even stem cell-derived islets, currently under trial, may soon expand accessibility. 'These developments represent a new dawn in diabetes care. While not yet a first-line treatment, islet cell transplantation is a vital option for patients struggling with the demands of insulin therapy. As research progresses, improvements in immunosuppression, donor matching, and cell supply are expected to make this treatment more widely available.'
Zawya
a day ago
- Zawya
KFSHRC Command Center atthe core of digital transformation and care excellence
King Faisal Specialist Hospital & Research Centre (KFSHRC) has advanced healthcare efficiency through its Capacity Command Center, a strategic pillar in the hospital's digital transformation journey. The Center has significantly optimized hospital-wide performance while delivering more responsive, patient-centered care. Established to modernize operations and elevate care, the Center provides real-time visibility across the patient journey—from admission to discharge—powered by a locally developed color-coded alert system that flags bottlenecks and enables timely intervention. This has improved operational efficiency and patient experience by streamlining admissions, discharges, and transfers, resulting in faster recovery, better resource use, and smoother clinical handovers. Building on this foundation, the Center leverages AI and big data to forecast patient volumes, identify pressure points, and guide precise resource allocation. These capabilities are reinforced by ongoing technical reporting, data mining, and performance reviews that translate insights into continuous institutional improvement. These innovations have led to a 14% reduction in average length of stay (ALOS) and a 19% drop in emergency department congestion, boosting patient recovery, bed availability, and patient safety. In parallel, overall hospital activity grew, with new patient admissions increasing by 10.3% to 46,476 in 2024, reflecting enhanced throughput and capacity management. Central to KFSHRC's transformation agenda, the Command Center exemplifies how AI and real-time analytics enable predictive, evidence-based decisions, advancing its mission to deliver high-quality, specialized care through a scalable intelligent healthcare model. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@
